Akane Miyazaki

Akane Miyazaki

Auto-generated profile, based on publicly available information

Akane Miyazaki

Department of Psychiatry, Hokkaido University Graduate School of Medicine, Sapporo 060-8638, Japan

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
HOHiroki Okano
Hiroki Okano
RKRyotaro Kubota
Ryotaro Kubota
RORyo Okubo
Ryo Okubo
NHNaoki Hashimoto
Naoki Hashimoto
SISatoru Ikezawa
Satoru Ikezawa
MMMasafumi Mizuno
Masafumi Mizuno
Social cognition is strongly linked to social functioning outcomes, making it a promising treatment target. Because social cognition measures tend to be sensitive to linguistic and cultural differences, existing measures should be evaluated based on their relevance for Japanese populations. We aimed to establish an expert consensus on the use of social cognition measures in Japanese populations to provide grounds for clinical use and future treatment development. We assembled a panel of experts in the fields of schizophrenia, social psychology, social neuroscience, and developmental disorders. The panel engaged in a modified Delphi process to (1) affirm expert consensus on the definition of social cognition and its constituent domains, (2) determine criteria to evaluate measures, and (3) identify measures appropriate for Japanese patients with a view toward future quantitative research. Through two online voting rounds and two online video conferences, the panel agreed upon a definition and four-domain framework for social cognition consistent with recent literature. Evaluation criteria for measures included feasibility and tolerability, reliability, clinical effectiveness, validity, and international comparability. The panel finally identified nine promising measures, including one task originally developed in Japan. In conclusion, we established an expert consensus on key discussion points in social cognition and arrived at an expert-selected set of measures. We hope that this work facilitates the use of these measures in Japanese clinical scenarios. We plan to further examine these measures in a psychometric evaluation study.

1 December 2019 in Neuropsychiatric Disease and Treatment
Verified
Journal Article
Open access
PDF file
NHNaoki Hashimoto
Naoki Hashimoto
ATAtsuhito Toyomaki
Atsuhito Toyomaki
MOMatsuhiko Oka
Matsuhiko Oka
KTKeisuke Takanobu
Keisuke Takanobu
RORyo Okubo
Ryo Okubo
IKIchiro Kusumi
Ichiro Kusumi
Purpose: The brief negative symptoms scale (BNSS) is a concise instrument used to assess negative symptoms of subjects with schizophrenia covering five domains of negative symptoms and is suitable for use in clinical, experimental, and epidemiological settings. The original and translated version of BNSS has thus far been shown to have adequate psychometric properties. This study aimed to examine internal consistency, inter-rater and test-retest reliability, discriminant and convergent validity, and factor structure of the Japanese version of BNSS. Patients and methods: The assessment was performed by 11 raters using interview videos of nine subjects. Reliability was calculated with Cronbach’s alpha for internal consistency and intra class correlation coefficient (ICC) for inter-rater reliability. Pearson’s correlation coefficients were calculated to estimate the test-retest reliability. In addition to BNSS, Scale for assessment of negative symptoms (SANS) and scale for assessment of positive symptoms (SAPS) was obtained to assess the convergent and discriminant validity. Factor structure was assessed using principle factor analysis. Results: The Japanese BNSS showed excellent internal consistency (Cronbach’s alpha=0.95), inter-rater reliability (intra class correlation coefficient=0.97), and test-retest reliability (r=0.94, p<0.001). The convergent validity shown by correlation with SANS total score (r=0.87, p<0.001) and discriminant validity shown by correlation with SAPS total score (r=0.17, p=−0.68) were also good. Principal factor analysis revealed a two-factor structure of BNSS, although the loading of each item differed from that in the literature. Conclusion: Our pilot study demonstrated that Japanese BNSS had good psychometric properties which were achieved with relatively brief training. Further studies with more subjects and raters with various backgrounds recruited from multiple sites are warranted.

Verified
Journal Article
Open access
PDF file
RKRyotaro Kubota
Ryotaro Kubota
RORyo Okubo
Ryo Okubo
HAHisashi Akiyama
Hisashi Akiyama
HOHiroki Okano
Hiroki Okano
SISatoru Ikezawa
Satoru Ikezawa
NHNaoki Hashimoto
Naoki Hashimoto
In schizophrenia, social cognitive impairment is considered one of the greatest obstacles to social participation. Although numerous measures have been developed to assess social cognition, only a limited number of them have become available in Japan. We are therefore planning this evaluation study for social cognition measures in Japan (ESCoM) to confirm their psychometric characteristics and to promote research focused on social cognition. Participants in the cross-sectional observational study will be 140 patients with schizophrenia recruited from three Japanese facilities and 70 healthy individuals. In our primary analysis, we will calculate several psychometric indicators with a focus on whether they can independently predict social functioning. In secondary analyses, we will assess the reliability and validity of the Japanese translations of each measure and conduct an exploratory investigation of patient background, psychiatric symptoms, defeatist performance belief, and gut microbiota as determinants of social cognition. The protocol for this study is registered in UMIN-CTR, unique ID UMIN000043777.

1 December 2020 in Asian Journal of Psychiatry
Verified
Journal Article
Closed access
NHNaoki Hashimoto
Naoki Hashimoto
KTKatsuyoshi Takahashi
Katsuyoshi Takahashi
DFDaisuke Fujisawa
Daisuke Fujisawa
KAKumi Aoyama
Kumi Aoyama
ANAtsuo Nakagawa
Atsuo Nakagawa
IKIchiro Kusumi
Ichiro Kusumi

1 August 2020 in Psychiatry Research
Verified
Journal Article
Closed access
KTKuniyoshi Toyoshima
Kuniyoshi Toyoshima
ATAtsuhito Toyomaki
Atsuhito Toyomaki
AMAkane Miyazaki
Akane Miyazaki
AMAnabel Martinez-Aran
Anabel Martinez-Aran
Eduard VietaEduard Vieta
Eduard Vieta
IKIchiro Kusumi
Ichiro Kusumi

13 November 2020
Verified
Journal Article
Open access
RYRyo Yamada
Ryo Yamada
SOSatoshi Okumura
Satoshi Okumura
YKYuji Kono
Yuji Kono
AMAkane Miyazaki
Akane Miyazaki
YNYudai Niwa
Yudai Niwa
HIHideo Izawa
Hideo Izawa
There are benefits of exercise-based cardiac rehabilitation (CR) in patients with heart failure (HF), but their underlying molecular mechanisms remain elusive. The effect of CR on the expression profile of circulating microRNAs (miRNAs), which are short noncoding RNAs that regulate posttranscriptional expression of target genes, is unknown. If miRNAs respond to changes following CR for HF, then serum profiling of miRNAs may reveal cardioprotective mechanisms of CR. This study enrolled three hospitalized patients with progressed systolic HF and three normal volunteer controls. In patients, CR was initiated after improvement of HF, which included 2 weeks of bicycle ergometer and resistance exercises. Genome-wide expression profiling of circulating miRNAs was performed using microarrays for the patients (mean±SD age, 60.0±12.2 years) and controls (58.7±0.58 years). Circulating miRNA expression profiles were compared between patients with HF before and after CR and the controls. Expression levels of two miRNAs were significantly different in patients before CR compared with controls and patients after CR. The expression of hsa-miR-125b-1-3p was significantly downregulated and that of hsa-miR-1290 was significantly upregulated in patients before CR. When performing CR, expression of certain circulating miRNAs in patients with HF is restored to nonpathological levels. The benefits of CR for HF may result from regulation of miRNAs through multiple effects of gene expression.